Andrew Morris - SQI Diagnostics CEO and President and Director

Mr. Andrew Morris is President, Chief Executive Officer, Director of SQI Diagnostics Inc., since April 2007. He joined the SQI Diagnostics team in 2004 with the key deliverables of growing and enhancing the Company financial position and corporate strategy. Andrew adds a wellrounded experience set gained in leadership roles in the areas of medical research, capital markets and corporate finance. Prior to joining SQI, Andrew led the Corporationrationrate Finance Life Sciences group at Ernst Young, advising private and public companies on a variety of business strategy and financial matters including private equity offerings, mergers and acquisitions, and strategic alliances. Prior to that, Andrew gained considerable transaction experience while working in senior corporate development and finance roles in high growth and startup companies. He also gained capital markets and equity research experience at Scotia Capital, while covering companies in the Healthcare and Biotechnology sector. Andrew background also includes eight years conducting research in the area of human performance enhancement at the Defence and Civil Institute of Environmental Medicine. He holds an Honours BS from the University of Western Ontario, a MS from the Faculty of Medicine at the University of Toronto, and a MBA degree from the Rotman School of Management at the University of Toronto. With experience in turning around, shaping and building companies, this team forms the optimum executive roster to propel SQI Diagnostics forward. since 2013.